SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

EP Biocomposites zooms on bagging order worth Rs 72.27 lakh

30 Nov 2023 Evaluate

EP Biocomposites is currently trading at Rs. 203.95, up by 11.95 points or 6.22% from its previous closing of Rs. 192.00 on the BSE.

The scrip opened at Rs. 193.50 and has touched a high and low of Rs. 203.95 and Rs. 191.15 respectively. So far 9000 shares were traded on the counter.

The BSE group 'M' stock of face value Rs. 10 has touched a 52 week high of Rs. 264.00 on 13-Feb-2023 and a 52 week low of Rs. 162.55 on 01-Feb-2023.

Last one week high and low of the scrip stood at Rs. 226.00 and Rs. 183.00 respectively. The current market cap of the company is Rs. 34.29 crore.

The promoters holding in the company stood at 70.08%, while Institutions and Non-Institutions held 2.20% and 27.72% respectively.

EP Biocomposites has received an order for design, supply, installation, testing and commissioning of sewage treatment plant (STP) of 100 KLD capacity (MBR based) including civil and electrification work with all necessary utilities from Oil and Natural Gas Corporation.

The order value is Rs 72.27 lakh. The prestigious order represents around 10% of the entire turnover from the previous financial year 2022-23 and is proposed to be completed within financial year 2023-24. 

EP Biocomposites is the manufacturer and supplier of fibre reinforced polymers (FRP) products such as door shutters, frames, Biodigestor Tanks, Bio toilets and allied products for construction and Industrial applications which meets customer requirements.

EP Biocomposites Share Price

92.00 0.00 (0.00%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Supreme Industries 3705.80
Astral 1612.85
Finolex Inds 174.70
Nilkamal 1320.05
Jain Irrigation Sys 33.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×